Jupiter Neurosciences, Inc. balance sheet

At the end of fiscal 2025, Jupiter Neurosciences, Inc. had total assets of $5.6m, total liabilities of $7.4m and shareholders' equity of −$1.8m.

Balance sheet

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Jupiter Neurosciences, Inc.: balance sheet, annual
Fiscal year	2024Dec 2024	2025Dec 2025
Receivables	—	3
Inventory	—	160
Total current assets	4,650	4,825
Total assets	6,202	5,564
Deferred revenue (current)	—	1
Total current liabilities	2,009	7,396
Total debt	649	5,298
Total liabilities	2,030	7,396
Shareholders' equity	4,172	−1,832
Shares outstanding	33m	—

US$ thousands unless shown otherwise. Fiscal quarters.

Jupiter Neurosciences, Inc.: balance sheet, quarterly
Quarter	2025 Q1Mar 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	—	—	10
Inventory	—	148	135
Total current assets	3,611	3,410	2,549
Total assets	4,963	3,949	3,719
Deferred revenue (current)	—	—	1
Total current liabilities	1,890	6,732	3,879
Total liabilities	1,898	6,732	4,085
Shareholders' equity	3,065	−2,783	−366
Shares outstanding	33m	36m	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Jupiter Neurosciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Jupiter Neurosciences, Inc.